Other News To Note
• Lorus Therapeutics Inc., of Toronto, signed a collaboration agreement with Brock University of St. Catherines, Ontario, for the development of cancer drugs based on chemical derivatives of the natural compound pancratistatin.
To continue reading subscribe now to BioWorld Today
Learn More about BioWorld Today
Already a subscriber? Sign In or Buy now to activate your subscription
Note: our contact information has changed
Customer Care: http://support.clarivate.com
© 2018 Clarivate Analytics.
Reproduction, reposting content is strictly prohibited.
Reproduction, reposting content is strictly prohibited.